Is Kybella still under patent, and when does its patent expire?
Kybella (deoxycholic acid) is an FDA-approved prescription treatment for submental fat. The exact expiration date depends on which specific patent or exclusivity you mean (drug composition, formulation, manufacturing process, or method-of-use), and on the later of: the patent term or any regulatory exclusivity periods tied to the FDA approval.
The information provided here does not include the patent numbers, assignee(s), or the filing/expiration dates needed to state a precise “expires on” date for Kybella.
What kinds of IP protect Kybella?
Kybella’s legal protection typically involves a mix of:
- Patents covering aspects of the drug (composition/formulation) and manufacturing
- Patents covering how it’s used (method-of-treatment claims)
- Regulatory exclusivity after FDA approval (which can delay generic competition even if a later patent expires)
Without the specific Kybella patent(s) at issue, it’s not possible to map which category controls the remaining protection.
Are there biosimilar/generic Kybella challengers?
For a drug like Kybella (a small-molecule drug product), the closest comparison is usually an ANDA-style “generic” path rather than biosimilar pathways. Whether challengers can launch depends on which patent(s) are listed, how they’re litigated, and what the relevant exclusivity already allows.
No litigation status or company challenge details are included here.
How to find the exact Kybella patent expiration date (fast)
To get the accurate expiration date, you need to look up:
1. The FDA Orange Book record for Kybella (active ingredient and NDA)
2. The patent list tied to that NDA (patent numbers and “expires on” dates)
3. Any relevant legal events (e.g., stays, court rulings) that affect launch timing
What’s the practical launch timing: patent expiry vs FDA exclusivity?
Even if a patent expires, launch timing can still be delayed by:
- Remaining regulatory exclusivity
- Another listed patent that is still in force (especially for method-of-use or formulation)
Conversely, if a patent is successfully challenged or narrowed, the practical timing can be earlier than the longest listed expiration date.
What I need to give you a precise answer
If you share either of the following, I can pinpoint the exact patent/exclusivity timeline:
- The Kybella NDA number (or NDC details), or
- Any Kybella patent number(s) you’re looking at
Sources: none provided (no Kybella patent data was included in the prompt).